Latest Anti-diabetic medication Stories

The DrugRisk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com New York, NY (PRWEB) May 02, 2013 The diabetes drug safety advocates at DrugRisk.com are announcing new information on the site for patients who have taken the diabetes medication Actos. A jury in the first Actos trial last week decided that the maker of the drug didn’t properly warn patients of bladder cancer risks****. The...

DEERFIELD, Ill., May 1, 2013 /PRNewswire/ -- Takeda Pharmaceuticals U.S.A., Inc. announced today that in the case of Jack Cooper, et al. v. Takeda Pharmaceuticals America, Inc., et al., No. CGC-12-518535, the judge granted Takeda's motion for non-suit. The ruling nullifies the jury's April 26 verdict, which had awarded plaintiffs $6.5 million in damages. The trial began in February. "We have empathy for Mr. Cooper and his family, but agree with the court's finding. In granting the...

DEERFIELD, Ill., April 26, 2013 /PRNewswire/ -- Takeda Pharmaceuticals U.S.A., Inc. announced today that in the case of Jack Cooper et al. v. Takeda Pharmaceuticals America, Inc., et al., No. CGC-12-518535 the jury found in favor of the plaintiffs and awarded a total of $6.5 million in damages. Takeda has filed motions asking the judge to rule in favor of the company as a matter of law and is considering its options, including a possible appeal if the motions are denied. The trial...

According to the Institute for Safe Medication Practices’ most recent QuarterWatch report, incretin mimetic drugs such as Byetta, Januvia and Victoza may be 25 times more likely to be linked to pancreatic cancer. This class of medications is currently under investigation by the U.S. Food and Drug Administration (FDA) after researchers found evidence of precancerous cell changes in pancreatic tissue samples from patients who took the Type 2 diabetes drugs. New York, New York (PRWEB) April...

The Law Offices of Berman and Berman have just announced that they are taking new Avandia lawsuit and compensation cases. They have successfully worked many cases for the generic drug Rosiglitazone, which goes by the brand name Avandia. New York, NY (PRWEB) April 19, 2013 The Berman Law Group are extending their legal efforts in fighting for justice for all people who have been potentially hurt by the drug Avandia. They are now taking new cases and are able to fight and potentially win...

redOrbit Staff & Wire Reports – Your Universe Online Three years after restricting sales of Avandia, the US Food and Drug Administration (FDA) has scheduled a health advisory panel to re-evaluate the safety of the diabetes drug, various media outlets reported on Friday. The FDA limited the availability of the pill to patients who could not control their diabetes with any other medication due to an increased risk of heart attack and death associated with the product, according to...

Increased number of consumer inquiries about legal rights being generated by reports from first trial involving allegations that long-term Actos use by patients with Type 2 diabetes could have serious side effects. San Diego, CA (PRWEB) April 07, 2013 http://www.resource4thepeople.com/defectivedrugs/Actos-Bladder-Cancer-Lawsuit.html Resource4thePeople announced today that its attorneys are now investigating 2013 claims from consumers over allegations that long-term use of the diabetes...

Even in Canada, the glycated hemoglobin levels of diabetic kids (type 1) are correlated with household income Researchers at the University of Montreal have found that the glycated hemoglobin levels of children with type 1 diabetes followed at its affiliated Sainte-Justine Mother and Child University Hospital (CHU Sainte-Justine) is correlated linearly and negatively with household income. Glycated hemoglobin is the binding of sugar to blood molecules – over time, high blood sugar levels...

redOrbit Staff & Wire Reports - Your Universe Online The US Food and Drug Administration (FDA) approved Invokana, the first of a new class of drugs that will treat patients suffering from type 2 diabetes, on Friday, various media outlets have reported. Rather than impacting the body’s supply or use of insulin like many existing types of diabetes medications, Invokana, which will be sold by Johnson & Johnson, causes blood sugar to be excreted in the urine, according to the New...

INVOKANA(TM) is the first in a new class of type 2 diabetes medications available in the United States RARITAN, N.J., March 29, 2013 /PRNewswire/ -- Janssen Pharmaceuticals, Inc. announced today the U.S. Food and Drug Administration (FDA) has approved INVOKANA(TM) (canagliflozin) for the treatment of adults with type 2 diabetes. INVOKANA(TM) is the first in a new class of medications called sodium glucose co-transporter 2 (SGLT2) inhibitors to be approved in the United States. It...